iAnthus Capital Holdings, Inc.
iAnthus Capital Holdings, Inc. (IAN.CN) Financial Performance & Income Statement Overview
Explore the financials of iAnthus Capital Holdings, Inc. (IAN.CN), including yearly and quarterly data on income, cash flow, and balance sheets.
iAnthus Capital Holdings, Inc. (IAN.CN) Income Statement & Financial Overview
Access detailed annual and quarterly income data for iAnthus Capital Holdings, Inc. IAN.CN financial performance.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $38.12M | $42.72M | $40.29M | $43.00M |
Cost of Revenue | $19.24M | $23.58M | $22.20M | $22.31M |
Gross Profit | $18.88M | $19.14M | $18.08M | $20.69M |
Gross Profit Ratio | $0.50 | $0.45 | $0.45 | $0.48 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $16.82M | $15.17M | $15.15M | $14.90M |
Operating Expenses | $16.82M | $21.21M | $19.34M | $20.91M |
Total Costs & Expenses | $36.06M | $43.55M | $41.54M | $43.22M |
Interest Income | $0.00 | $906000.00 | $817000.00 | $2.78M |
Interest Expense | -$4.21M | $5.63M | $5.54M | $5.41M |
Depreciation & Amortization | $4.22M | $6.04M | $6.12M | $6.20M |
EBITDA | $9.17M | $4.73M | $5.66M | $5.98M |
EBITDA Ratio | $0.24 | $0.11 | $0.14 | $0.14 |
Operating Income | -$2.01M | -$2.07M | -$1.26M | -$225000.00 |
Operating Income Ratio | -$0.05 | -$0.05 | -$0.03 | -$0.005 |
Other Income/Expenses (Net) | $11.17M | -$4.74M | -$4.74M | -$2.64M |
Income Before Tax | $9.16M | -$6.81M | -$6.00M | -$2.87M |
Income Before Tax Ratio | $0.24 | -$0.16 | -$0.15 | -$0.07 |
Income Tax Expense | $4.009M | -$34.60M | $5.64M | $6.92M |
Net Income | $5.15M | $27.73M | -$11.64M | -$9.79M |
Net Income Ratio | $0.14 | $0.65 | -$0.29 | -$0.23 |
EPS | $0.001 | $0.004 | -$0.002 | -$0.002 |
Diluted EPS | $0.001 | $0.004 | -$0.002 | -$0.002 |
Weighted Avg Shares Outstanding | $6.74B | $6.54B | $6.52B | $6.51B |
Weighted Avg Shares Outstanding (Diluted) | $6.74B | $6.54B | $6.52B | $6.51B |
Over the past four quarters, iAnthus Capital Holdings, Inc. demonstrated steady revenue growth, increasing from $43.00M in Q2 2024 to $38.12M in Q1 2025. Operating income reached -$2.01M in Q1 2025, maintaining a consistent -5% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $9.17M, reflecting operational efficiency. Net income dropped to $5.15M, with EPS at $0.001. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan